Skip to content
Screener

AOCI at other companies

Baxter International logo
Baxter InternationalBAX
-$3.8B+3.6%
Revvity logo
RevvityRVTY
-$253.56M+19.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
-$13.95B+2.5%
Utah Medical Products logo
Utah Medical ProductsUTMD
-$9.92M+11.4%
AbbVie logo
AbbVieABBV
-$1.15B+33.8%
Medtronic logo
MedtronicMDT
-$4.1B+4.3%

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$14.6B+7.4%
Enterprise value$17.52B+9.5%
P/E61.9×+28.6×
P/S3.5×+0.1×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The source filing: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026.

Filed
Jun 5, 2026, 4:47 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-041305
Line itemApril 30, 2026October 31, 2025
Preferred stock, $0.10 par value, 1.0 shares authorized, zero shares issued or outstanding
Common stock, $0.10 par value, 480.0 shares authorized, 217.9 issued and 194.9 outstanding at April 30, 2026, and 217.6 issued and 195.9 outstanding at October 31, 202521.821.8
Additional paid-in capital1,982.61,975.5
Accumulated other comprehensive loss(363.2)(406.5)
Retained earnings7,696.27,643.3
Treasury stock at cost: 23.0 shares at April 30, 2026, and 21.7 shares at October 31, 2025(1,098.5)(995.2)
Total Cooper stockholders’ equity8,238.98,238.9
Noncontrolling interests0.20.2

Item 1. Unaudited Financial Statements

FAQ

What is The Cooper Companies, Inc.'s AOCI?
The Cooper Companies, Inc. (COO) reported AOCI of -$363.2M in Q1 2026.
How has The Cooper Companies, Inc.'s AOCI changed year-over-year?
The Cooper Companies, Inc.'s AOCI increased by 7.4% year-over-year, from -$392.3M to -$363.2M.
What is the long-term trend for The Cooper Companies, Inc.'s AOCI?
Over 5 years (2020 to 2025), The Cooper Companies, Inc.'s AOCI has grown at a -2.9% compound annual growth rate (CAGR), from -$472M to -$406.5M.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Ask your AI about The Cooper Companies, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude